On March 13, 2024, DOWRAB, an anti-rabies vaccine developed by Dow University of Health Sciences, was officially launched, marking a significant milestone. The ceremony, attended by the Honorable Vice Chancellor, Prof. Mohammed Saeed Quraishy T.I., marked the start of a new era in the fight against rabies. Preclinical & Challenge studies of Dow RAB (Anti –Rabies Vaccine), carried out in DIABAR to launch the first Biological product by Dow University of Health Sciences.